Microbot Medical Inc. Financial Ratios
MBOT|FY2015 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2015 SEC 10-K data.
Key Data Points
- Altman Z-Score -2.00 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2015)
Return on Equity
-176.8%
Profit Margin
-15345.1%
Net Income / Revenue
Asset Turnover
0.01
Revenue / Total Assets
Equity Multiplier
2.17
Total Assets / Equity
Composite: -176.8% (reported: -176.8%)
Profitability
Liquidity
Current Ratio
2.31
Quick Ratio
2.31
Solvency
Interest Coverage
-19.99
Efficiency
Asset Turnover
0.01
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2015 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-9.6%
+17.0pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.